Cargando…

5-Lipoxygenase Activating Protein (FLAP) Dependent Leukotriene Biosynthesis Inhibition (MK591) Attenuates Lipid A Endotoxin-Induced Inflammation

The Lipid A moiety of endotoxin potently activates TLR-4 dependent host innate immune responses. We demonstrate that Lipid-A mediated leukotriene biosynthesis regulates pathogen-associated molecular patterns (PAMP)-dependent macrophage activation. Stimulation of murine macrophages (RAW264.7) with E....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Wen-Feng, Douglas, Ivor S., Wang, Chin-Chou, Kao, Hsu-Ching, Chang, Ya-Ting, Tseng, Chia-Cheng, Huang, Kuo-Tung, Chang, Huang-Chih, Lin, Meng-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099325/ https://www.ncbi.nlm.nih.gov/pubmed/25025775 http://dx.doi.org/10.1371/journal.pone.0102622

Ejemplares similares

Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone
Publicado: (1989)

Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201
por: Kretzer, Christian, et al.
Publicado: (2022)

New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis
por: Boudreau, Luc H., et al.
Publicado: (2017)

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators
por: Dahlke, Philipp, et al.
Publicado: (2023)

MK591, a Second Generation Leukotriene Biosynthesis Inhibitor, Prevents Invasion and Induces Apoptosis in the Bone-Invading C4-2B Human Prostate Cancer Cells: Implications for the Treatment of Castration-Resistant, Bone-Metastatic Prostate Cancer
por: Sarveswaran, Sivalokanathan, et al.
Publicado: (2015)

The Role of 5-Lipoxygenase and Leukotrienes in Shock and Ischemia-Reperfusion Injury
por: Rossi, Antonietta, et al.
Publicado: (2007)

Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling
por: Horn, Thomas, et al.
Publicado: (2015)

Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein
por: Olğaç, Abdurrahman, et al.
Publicado: (2023)

miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells
por: Iacona, Joseph R., et al.
Publicado: (2018)

Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A(4) Hydrolase
por: Teder, Tarvi, et al.
Publicado: (2023)

Comparing survival and treatment response of patients with acquired T790M mutation second‐line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A real‐world study
por: Wang, Chin‐Chou, et al.
Publicado: (2021)

Leukotrienes: Biosynthesis, Metabolism, and Pathophysiologic Significance
por: Mayatepek, Ertan, et al.
Publicado: (1995)

Cysteinyl Leukotriene Pathway and Cancer
por: Tsai, Ming-Ju, et al.
Publicado: (2021)

The Influence of Obesity on Different Genders in Patients with Obstructive Sleep Apnea
por: Huang, Kuo-Tung, et al.
Publicado: (2014)

Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B(4) pathway by high-density lipoprotein in macrophages
por: Tsuda, Shigeyasu, et al.
Publicado: (2017)

MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication
por: Ruiz, Isaac, et al.
Publicado: (2020)

Involvement of 5-lipoxygenase/cysteinyl leukotriene receptor 1 in rotenone- and MPP+-induced BV2 microglial activation
por: Wang, Yanfang, et al.
Publicado: (2012)

Regulation of leukotriene and 5oxoETE synthesis and the effect of 5-lipoxygenase inhibitors: a mathematical modeling approach
por: Karelina, Tatiana A, et al.
Publicado: (2012)

The role of leukotriene inhibition using a 5-lipoxygenase (5-LO) inhibitor in a joint contracture model
por: Jeffs, Alexander D., et al.
Publicado: (2023)

Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Comprehensive analysis of PD‐L1 in non‐small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue
por: Wang, Chin‐Chou, et al.
Publicado: (2021)

Two-year quality of life after free flap reconstruction in tumor-site discrepancy among Taiwanese with moderately advanced oral squamous cell carcinoma
por: Chang, Kao-Ping, et al.
Publicado: (2012)

Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1
por: Huang, Xue-Qin, et al.
Publicado: (2012)

Corrigendum: Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients
por: Tsai, Ming-Ju, et al.
Publicado: (2016)

Human CMV infection induces 5-lipoxygenase expression and leukotriene B(4) production in vascular smooth muscle cells
por: Qiu, Hong, et al.
Publicado: (2008)

Repeated allergen exposure reduce early phase airway response and leukotriene release despite upregulation of 5-lipoxygenase pathways
por: Cui, Zhi-Hua, et al.
Publicado: (2012)

Systemic inhibition of 5-lipoxygenase by MK-886 exacerbates apical periodontitis bone loss in a mouse model
por: Petean, Igor Bassi Ferreira, et al.
Publicado: (2023)

Role of Tomato Lipoxygenase D in Wound-Induced Jasmonate Biosynthesis and Plant Immunity to Insect Herbivores
por: Yan, Liuhua, et al.
Publicado: (2013)

Anti-Inflammatory Effects of GM1 Ganglioside on Endotoxin-Induced Uveitis in Rats
por: Weng, Tzu-Heng, et al.
Publicado: (2022)

Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta‐analysis of real‐world survival outcomes of East Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR‐TKIs
por: Chang, Huang‐Chih, et al.
Publicado: (2023)

Leukotriene C(4) biosynthesis in isolated August rat peritoneal leukocytes
por: Huebner, J. M., et al.
Publicado: (1996)

Transcellular biosynthesis of leukotriene B(4) orchestrates neutrophil swarming to fungi
por: Hopke, Alex, et al.
Publicado: (2022)

Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence
por: Chang, Huang‐Chih, et al.
Publicado: (2023)

Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010)

Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value
por: Tseng, Chia-Cheng, et al.
Publicado: (2013)

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
por: Wang, Chin-Chou, et al.
Publicado: (2017)

Ventilator Dependence Risk Score for the Prediction of Prolonged Mechanical Ventilation in Patients Who Survive Sepsis/Septic Shock with Respiratory Failure
por: Chang, Ya-Chun, et al.
Publicado: (2018)

Effects of Hepatocyte CD14 Upregulation during Cholestasis on Endotoxin Sensitivity
por: Chou, Ming-Huei, et al.
Publicado: (2012)

SUN-591 Severe Iron-Deficiency Anemia Leading to Hypothyroidism
por: Ghiya, Ronak, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v5s0uamsli8fn7vsu4f4pi16qb